Trial
NCT03636373
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
Amgen
Condition
Gout Attack
Intervention
Etanercept
Why stopped
The Sponsor has decided to stop funding this study due to lack of enrollment during COVID-19 pandemic and decreased interest in funding investigator initiated studies pertaining to the study drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-27